Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New spine procedure tracked in 1,500 patients for back pain relief

NCT ID NCT06827262

Symptom relief Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 21, 2026 · Updated 11 times

Summary

This study is following 1,500 people with chronic low back pain caused by a condition called vertebrogenic pain syndrome. All participants will receive the Intracept procedure, which uses radiofrequency energy to ablate (disable) certain nerves in the spine thought to cause pain. The main goal is to see how much their disability changes over time using a standard questionnaire. This is an observational study, meaning researchers are just watching what happens in real-world use, not comparing it to another treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Intracept™ Intraosseous Nerve Ablation (a device procedure that uses radiofrequency energy to ablate nerves in the spine)
What this could lead to
If successful, this could confirm that the Intracept procedure is a safe and effective option for people with chronic vertebrogenic back pain, potentially reducing disability and improving quality of life.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. The procedure is already approved, but individual outcomes can vary, and there are risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Jul 2034

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects are established patients in a medical practice who will receive intraosseous nerve ablation to treat vertebrogenic pain utilizing a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use according to standard of care.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU). * Signed a valid, IRB/EC-approved informed consent form. Exclusion Criteria: * Meets any contraindications per locally applicable Instructions for Use (IFU).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic low back pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Back Pain Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic low back pain Vertebrogenic pain syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    20 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Allegheny General Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15212, United States

  • CentraCare Health System

    RECRUITING

    Saint Cloud, Minnesota, 56303, United States

  • Commonwealth Pain and Spine

    RECRUITING

    Lexington, Kentucky, 40509, United States

  • Cy-Pain and Spine

    RECRUITING

    Houston, Texas, 77065, United States

  • Flagstaff Bone & Joint

    RECRUITING

    Flagstaff, Arizona, 86001, United States

  • Horizon Clinical Research, LLC

    RECRUITING

    Jasper, Georgia, 30143, United States

  • Illinois Bone and Joint Institute

    RECRUITING

    Barrington, Illinois, 60010, United States

  • Innovative Pain and Wellness

    RECRUITING

    Phoenix, Arizona, 85014, United States

  • MarinHealth Spine Institute

    RECRUITING

    Larkspur, California, 94939, United States

  • Montefiore Medical Center

    RECRUITING

    The Bronx, New York, 10461, United States

  • New York Spine and Pain Specialists

    RECRUITING

    Port Jefferson Station, New York, 11776, United States

  • North Idaho Day Surgery, LLC

    WITHDRAWN

    Post Falls, Idaho, 83854, United States

  • Novant Health Spine Specialists

    RECRUITING

    Bermuda Run, North Carolina, 27106, United States

  • Ochsner Clinic Foundation

    RECRUITING

    New Orleans, Louisiana, 70115, United States

  • Orlando Regional Medical Center

    RECRUITING

    Orlando, Florida, 32806, United States

  • Pacific Sports and Spine

    ACTIVE_NOT_RECRUITING

    Eugene, Oregon, 97404, United States

  • Stanford University Medical Center

    RECRUITING

    Stanford, California, 94305, United States

  • The Spine Wellness Center in Westport

    RECRUITING

    Westport, Connecticut, 06880, United States

  • University of Rochester

    RECRUITING

    Rochester, New York, 14618, United States

  • University of Utah Orthopaedic Center

    RECRUITING

    Salt Lake City, Utah, 84108, United States

  • Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • iSpine Clinics

    RECRUITING

    Maple Grove, Minnesota, 55369, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.